MBRX · Categories · Form 4

MBRX - SEC Form 4 insider transactions

Moleculin Biotech Inc. (MBRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MBRX

• 206d
  SEC Form 4 filed by CSO Picker Donald H

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 206d
  SEC Form 4 filed by EVP & CFO Foster Jonathan P.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 206d
  SEC Form 4 filed by CEO and President Klemp Walter V

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 206d
  SEC Form 4 filed by Director Yan Joy

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 206d
  SEC Form 4 filed by Director Cermak Elizabeth

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 206d
  SEC Form 4 filed by Director Cannon Michael D

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 206d
  SEC Form 4 filed by Director Climaco John M

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 206d
  SEC Form 4 filed by Director George Robert E.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 214d
  Chief Science Officer Picker Donald H converted options into 8,750 shares and covered exercise/tax liability with 2,131 shares, increasing direct ownership by 65% to 16,771 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 214d
  CEO and President Klemp Walter V converted options into 28,750 shares and covered exercise/tax liability with 7,001 shares, increasing direct ownership by 3% to 765,356 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 214d
  Chief Financial Officer Foster Jonathan P. converted options into 20,625 shares, increasing direct ownership by 5% to 303,189 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 350d
  Chief Science Officer Picker Donald H converted options into 2,844 shares and covered exercise/tax liability with 693 shares, increasing direct ownership by 27% to 10,152 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 355d
  Chief Financial Officer Foster Jonathan P. converted options into 833 shares and covered exercise/tax liability with 203 shares, increasing direct ownership by 6% to 11,993 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 355d
  CEO and President Klemp Walter V converted options into 1,667 shares and covered exercise/tax liability with 406 shares, increasing direct ownership by 2% to 58,296 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 579d
  SEC Form 4 filed by Director Yan Joy

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 579d
  SEC Form 4 filed by Director Cermak Elizabeth

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 579d
  SEC Form 4 filed by Director Climaco John M

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 579d
  SEC Form 4 filed by Director George Robert E.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 579d
  SEC Form 4 filed by Chief Science Officer Picker Donald H

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 579d
  SEC Form 4 filed by Director Cannon Michael D

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 579d
  SEC Form 4 filed by Chief Financial Officer Foster Jonathan P.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 579d
  SEC Form 4 filed by CEO and President Klemp Walter V

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 703d
  CEO and President Klemp Walter V converted options into 982 shares and covered exercise/tax liability with 240 shares, increasing direct ownership by 1% to 57,035 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 713d
  Chief Science Officer Picker Donald H converted options into 1,766 shares, increasing direct ownership by 18% to 8,001 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 713d
  Chief Financial Officer Foster Jonathan P. converted options into 4,329 shares and covered exercise/tax liability with 1,053 shares, increasing direct ownership by 41% to 11,363 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 713d
  CEO and President Klemp Walter V converted options into 8,990 shares and covered exercise/tax liability with 2,190 shares, increasing direct ownership by 14% to 56,293 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 717d
  Chief Science Officer Picker Donald H covered exercise/tax liability with 320 shares and converted options into 1,078 shares, increasing direct ownership by 13% to 6,759 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 717d
  Chief Financial Officer Foster Jonathan P. converted options into 2,712 shares and covered exercise/tax liability with 636 shares, increasing direct ownership by 35% to 8,087 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 717d
  CEO and President Klemp Walter V converted options into 3,750 shares and covered exercise/tax liability with 914 shares, increasing direct ownership by 6% to 49,493 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 720d
  Chief Financial Officer Foster Jonathan P. converted options into 834 shares and covered exercise/tax liability with 196 shares, increasing direct ownership by 12% to 6,011 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 720d
  CEO and President Klemp Walter V converted options into 1,667 shares and covered exercise/tax liability with 406 shares, increasing direct ownership by 3% to 46,657 units (SEC Form 4)

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1061d
  SEC Form 4 filed by Klemp Walter V

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1069d
  SEC Form 4 filed by Klemp Walter V

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1078d
  SEC Form 4 filed by Foster Jonathan P.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1078d
  SEC Form 4 filed by Klemp Walter V

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1078d
  SEC Form 4 filed by Picker Donald H

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1082d
  SEC Form 4 filed by Picker Donald H

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1082d
  SEC Form 4 filed by Foster Jonathan P.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1082d
  SEC Form 4 filed by Klemp Walter V

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1084d
  SEC Form 4 filed by Foster Jonathan P.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1084d
  SEC Form 4 filed by Klemp Walter V

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1109d
  SEC Form 4 filed by Yan Joy

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1109d
  SEC Form 4 filed by Cermak Elizabeth

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1109d
  SEC Form 4 filed by Climaco John M

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1109d
  SEC Form 4 filed by Cannon Michael D

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1109d
  SEC Form 4 filed by George Robert E.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1288d
  SEC Form 4: Klemp Walter V bought $57,632 worth of shares (45,000 units at $1.28), increasing direct ownership by 12% to 409,890 units

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1294d
  SEC Form 4: Klemp Walter V bought $25,866 worth of shares (22,500 units at $1.15), increasing direct ownership by 7% to 364,890 units

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1298d
  SEC Form 4: Klemp Walter V bought $107,871 worth of shares (109,955 units at $0.98), increasing direct ownership by 47% to 342,390 units

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1424d
  SEC Form 4: Klemp Walter V converted options into 13,204 shares and covered exercise/tax liability with 3,215 shares, increasing direct ownership by 4% to 232,435 units (Amendment)

  4/A - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1424d
  SEC Form 4: Klemp Walter V converted options into 14,717 shares and covered exercise/tax liability with 3,584 shares, increasing direct ownership by 5% to 222,446 units (Amendment)

  4/A - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1424d
  SEC Form 4 filed by Klemp Walter V (Amendment)

  4/A - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1426d
  SEC Form 4: Klemp Walter V converted options into 13,204 shares and covered exercise/tax liability with 3,215 shares, increasing direct ownership by 4% to 232,435 units

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1433d
  SEC Form 4: Klemp Walter V converted options into 14,717 shares and covered exercise/tax liability with 3,584 shares, increasing direct ownership by 5% to 222,446 units

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1447d
  SEC Form 4 filed by Picker Donald H

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1447d
  SEC Form 4 filed by Foster Jonathan P.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1447d
  SEC Form 4 filed by Klemp Walter V

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1447d
  SEC Form 4 filed by Climaco John M

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1447d
  SEC Form 4 filed by George Robert E.

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
• 1447d
  SEC Form 4 filed by Cannon Michael D

  4 - Moleculin Biotech, Inc. (0001659617) (Issuer)

Other MBRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends